Literature DB >> 8324897

The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

M Villacres-Eriksson1, M Bergström-Mollaoglu, H Kåberg, K Lövgren, B Morein.   

Abstract

The kinetics of the expression of membrane-associated IL-1 (mIL-1) and soluble IL-1 (sIL-1) was studied in in vitro stimulated spleen cells from non-primed mice or from mice primed with influenza virus antigens incorporated in the immuno-stimulating complexes (iscoms) or as micelles. Matrix, which is the carrier structure for the antigens in the iscom, was used as a non-antigen stimulus. The IL-1 produced was assayed in an IL-1-dependent cell line and the specificity was demonstrated in a blocking experiment with antiserum to IL-1 alpha. Soluble IL-1 alpha was also quantified in ELISA. Iscoms and matrix induced production of mIL-1 and sIL-1 in cultures from non-treated mice as well as from mice primed 4 days before with iscoms or micelles. Micelles were a less strong stimulus and did not induce production of sIL-1. Micelles induced production of mIL-1 in cultures from non-primed mice or from mice which were recently immunized with micelles. No mIL-1 expression was induced by micelles if the spleen cells originated from mice immunized shortly before with iscoms. Depletion experiments demonstrated that sIL-1 was produced by adherent cells upon stimulation with iscoms or matrix. However, factor(s) from the non-adherent cells seem to be necessary for optimal secretion of sIL-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324897      PMCID: PMC1554748          DOI: 10.1111/j.1365-2249.1993.tb06507.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier.

Authors:  K Lövgren; J Lindmark; R Pipkorn; B Morein
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

2.  In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli.

Authors:  E A Kurt-Jones; H W Virgin; E R Unanue
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

3.  Effective subunit vaccines against an enveloped animal virus.

Authors:  B Morein; A Helenius; K Simons; R Pettersson; L Kääriäinen; V Schirrmacher
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

Review 4.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Relationship of macrophage Ia and membrane IL 1 expression to antigen presentation.

Authors:  E A Kurt-Jones; H W Virgin; E R Unanue
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

6.  Presentation of antigen by B cells: functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation.

Authors:  M Frohman; C Cowing
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

Review 7.  Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.

Authors:  B Morein; K Simons
Journal:  Vaccine       Date:  1985-06       Impact factor: 3.641

8.  Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.

Authors:  J J Oppenheim; A Togawa; L Chedid; S Mizel
Journal:  Cell Immunol       Date:  1980-03-01       Impact factor: 4.868

Review 9.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

10.  Identification of a membrane-associated interleukin 1 in macrophages.

Authors:  E A Kurt-Jones; D I Beller; S B Mizel; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  3 in total

1.  Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice.

Authors:  Y Niki; H Yamada; S Seki; T Kikuchi; H Takaishi; Y Toyama; K Fujikawa; N Tada
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.

Authors:  M Villacres-Eriksson
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

3.  Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.

Authors:  Kylie M Quinn; Ayako Yamamoto; Andreia Costa; Patricia A Darrah; Ross W B Lindsay; Sonia T Hegde; Teresa R Johnson; Barbara J Flynn; Karin Loré; Robert A Seder
Journal:  J Immunol       Date:  2013-10-02       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.